Leukotrien A4 hydrolase as a target for cancer prevention.

被引：0
|
作者：
Chen, XX [1 ]
Wang, S [1 ]
Yang, CS [1 ]
机构：
[1] Rutgers State Univ, Piscataway, NJ USA
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2003年 / 12卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1287S / 1287S
页数：1
相关论文
共 50 条
  • [41] Role of Leukotriene A4 Hydrolase Aminopeptidase in the Pathogenesis of Emphysema
    Paige, Mikell
    Wang, Kan
    Burdick, Marie
    Park, Sunhye
    Cha, Josiah
    Jeffery, Erin
    Sherman, Nicholas
    Shim, Y. Michael
    JOURNAL OF IMMUNOLOGY, 2014, 192 (11): : 5059 - 5068
  • [42] Ubiquitous localization of leukotriene A4 hydrolase in the rat nephron
    Nakao, A
    Watanabe, T
    Ohishi, N
    Toda, A
    Asano, K
    Taniguchi, S
    Nosaka, K
    Noiri, E
    Suzuki, T
    Sakai, T
    Kurokawa, K
    Shimizu, T
    Kimura, S
    KIDNEY INTERNATIONAL, 1999, 55 (01) : 100 - 108
  • [43] Development of a potent and selective inhibitor of leukotriene A4 hydrolase
    Wei, JM
    Tays, K
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U150 - U150
  • [44] Cerebral Oxidative Stress as Mibyo Pathology:Target for Disease Prevention.
    Tetsuya Konishi
    长春中医药大学学报, 2008, (05) : 599 - 599
  • [45] Shared tumor antigens as vaccines for cancer prevention.
    Finn, OJ
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1255S - 1255S
  • [46] The molecular actions of vitamin A (retinol) in cancer prevention.
    Gudas, LJ
    Guo, XJ
    Li, R
    Liu, LM
    Mongan, NP
    Su, D
    Touma, SE
    Zhan, HC
    Zhuang, Y
    Bok, D
    Rando, RR
    Nanus, DM
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1256S - 1256S
  • [47] New developments in cervical cancer screening and prevention.
    Allwright, S
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 1997, 7 (04): : 457 - 458
  • [48] The role of cell death regulation in cancer prevention.
    Thompson, CB
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (11) : 2771S - 2771S
  • [49] The promise of surrogate end points in cancer prevention.
    Hawk, ET
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (11) : 1948S - 1948S
  • [50] Methodological approaches for application of pharmacogenetics to cancer prevention.
    Rebbeck, TR
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1239S - 1239S
12345